Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mattila

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Future Oncology (London, England)|September 30, 2024
Real-world results of first-line immunotherapy or targeted therapy for metastatic melanoma in Finland: a cohort studyKalle E Mattila, Leena Tiainen, Johanna Vikkula, et al.
Scientific Reports|April 22, 2021
A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinomaKalle E Mattila, Teemu D Laajala, Sara V Tornberg, et al.
Acta Oncologica (Stockholm, Sweden)|October 29, 2022
Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitorKalle E Mattila, Siru Mäkelä, Soili Kytölä, et al.
Endocrinology|September 9, 2020
Loss of CREBRF Reduces Anxiety-like Behaviors and Circulating Glucocorticoids in Male and Female MiceKrystle A Frahm, Akeem A Williams, Ashlee N Wood, et al.
Clinical Lung Cancer|February 11, 2023
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 MonotherapyHannes Vihinen, Artturi Jokinen, Teemu D Laajala, et al.
Melanoma Research|June 16, 2021
Isolated limb perfusion with melphalan as treatment for regionally advanced melanoma of the limbs: results of 60 patients treated in Finland during 2007-2018Sanni K A Tulokas, Laura M Kohtamäki, Siru P Mäkelä, et al.
Theranostics|January 29, 2026
Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCCTeijo Pellinen, Lassi Luomala, Kalle E Mattila, et al.
Plos One|September 14, 2021
A murine model of the human CREBRFR457Q obesity-risk variant does not influence energy or glucose homeostasis in response to nutritional stressJitendra S Kanshana, Polly E Mattila, Michael C Ewing, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 31, 2025
Investigating the role of adipose tissue in mobility and aging: design and methods of the Adipose Tissue ancillary to the Study of Muscle, Mobility, and Aging (SOMMA-AT)Reichelle X Yeo, Theresa Mau, Zana M Ross, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Future Oncology (London, England)|September 30, 2024
Real-world results of first-line immunotherapy or targeted therapy for metastatic melanoma in Finland: a cohort studyKalle E Mattila, Leena Tiainen, Johanna Vikkula, et al.
Scientific Reports|April 22, 2021
A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinomaKalle E Mattila, Teemu D Laajala, Sara V Tornberg, et al.
Acta Oncologica (Stockholm, Sweden)|October 29, 2022
Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitorKalle E Mattila, Siru Mäkelä, Soili Kytölä, et al.
Endocrinology|September 9, 2020
Loss of CREBRF Reduces Anxiety-like Behaviors and Circulating Glucocorticoids in Male and Female MiceKrystle A Frahm, Akeem A Williams, Ashlee N Wood, et al.
Clinical Lung Cancer|February 11, 2023
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 MonotherapyHannes Vihinen, Artturi Jokinen, Teemu D Laajala, et al.
Melanoma Research|June 16, 2021
Isolated limb perfusion with melphalan as treatment for regionally advanced melanoma of the limbs: results of 60 patients treated in Finland during 2007-2018Sanni K A Tulokas, Laura M Kohtamäki, Siru P Mäkelä, et al.
Theranostics|January 29, 2026
Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCCTeijo Pellinen, Lassi Luomala, Kalle E Mattila, et al.
Plos One|September 14, 2021
A murine model of the human CREBRFR457Q obesity-risk variant does not influence energy or glucose homeostasis in response to nutritional stressJitendra S Kanshana, Polly E Mattila, Michael C Ewing, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 31, 2025
Investigating the role of adipose tissue in mobility and aging: design and methods of the Adipose Tissue ancillary to the Study of Muscle, Mobility, and Aging (SOMMA-AT)Reichelle X Yeo, Theresa Mau, Zana M Ross, et al.
Pageof 5